The future of precision medicine
As part of EPR’s Women in Pharma series, Ruth March,…
16 January 2019 | By Dr Zara Kassam (European Pharmaceutical Review)
As part of EPR’s Women in Pharma series, Ruth March, VP and Head of Precision Medicine and Genomics at AstraZeneca, talks to Science Editor Dr Zara Kassam about decreasing the clinical risk associated with solid tumour biopsy, balancing a scientific career with family life and taking advantage of company initiatives…
Follow: